亚太地区皮下注射针市场预测至 2028 年 - COVID-19 影响和区域分析（按类型（安全针和非安全针）、应用（药物输送、疫苗接种和血液样本采集）、最终用户（诊断中心、医院）和诊所、家庭保健）和用途（一次性和可重复使用）
No. of Pages: 140 | Report Code: TIPRE00026207 | Category: Life Sciences
No. of Pages: 140 | Report Code: TIPRE00026207 | Category: Life Sciences
随着对皮下注射针头的需求不断增长，对皮下注射针头的需求也不断增长。针对 COVID-19 的疫苗正在增加。因此，市场参与者积极参与COVID-19大流行期间的市场开发活动。例如，2021年4月，三泽医疗工业株式会社开发了“低死腔针”，可以减少注射器中残留的药液量，并将于2021年4月1日开始在日本销售。消除了对特定注射器的需要，并减少了液体在注射器中滞留的“死区”。此外，辉瑞公司开发的一瓶新冠疫苗可提供六次注射。 2020年6月，三泽医疗工业株式会社扩建了针头制造设施，将年产能从19亿支提高到30亿支。公司目前正在强化疫苗针生产体系，同时启用其他产品生产线，公司将继续努力，让疫苗接种变得更简单。
借助新功能和技术，供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会推动皮下注射针头市场的发展。预计亚太地区皮下注射针市场在预测期内将以良好的复合年增长率增长。
亚太地区皮下注射针市场收入及到 2028 年的预测（百万美元）
亚太地区皮下注射针头市场细分
提及的公司
Strategic insights for Asia Pacific Hypodermic Needles involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 668.7 Million |
| Market Size by 2028 | US$ 1,092.6 Million |
| Global CAGR (2021 - 2028) | 7.3% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 类型
|
| Regions and Countries Covered | 亚太地区
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific Hypodermic Needles refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Hypodermic Needles Market is valued at US$ 668.7 Million in 2021, it is projected to reach US$ 1,092.6 Million by 2028.
As per our report Asia Pacific Hypodermic Needles Market, the market size is valued at US$ 668.7 Million in 2021, projecting it to reach US$ 1,092.6 Million by 2028. This translates to a CAGR of approximately 7.3% during the forecast period.
The Asia Pacific Hypodermic Needles Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Hypodermic Needles Market report:
The Asia Pacific Hypodermic Needles Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Hypodermic Needles Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Hypodermic Needles Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Hypodermic Needles Market
